RISTABEN

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Italy, Lithuania, Netherlands, Poland, South Africa, Spain, UK.

Active ingredients

The drug RISTABEN contains one active pharmaceutical ingredient (API):

1	Sitagliptin UNII TS63EW8X6F - SITAGLIPTIN PHOSPHATE
	Sitagliptin is a member of a class of oral anti-hyperglycaemic agents called dipeptidyl peptidase 4 (DPP-4) inhibitors. The improvement in glycaemic control observed with this medicinal product may be mediated by enhancing the levels of active incretin hormones.
	Read more about Sitagliptin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RISTABEN Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BH01	Sitagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
Discover more medicines within A10BH01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1464342, 1464353, 1464364, 1464375, 1464386, 1464397, 1464409, 1464410, 1464421, 1464432, 1464443, 1464454, 1464465, 1464476, 1464487, 1464498, 1464500, 1464511, 1661947, 1661958, 1661969, 1661970, 1661981, 1661992
ES	Centro de información online de medicamentos de la AEMPS	10621014, 10621015, 110621002, 110621008
GB	Medicines & Healthcare Products Regulatory Agency	391021
IT	Agenzia del Farmaco	043563194, 043563206, 043563218, 043563220, 043563232, 043563244
LT	Valstybinė vaistų kontrolės tarnyba	1053711, 1053712, 1053713, 1053714, 1053715, 1053716, 1053717, 1053718, 1053719, 1053720, 1053721, 1053722, 1053723, 1053724, 1053725, 1053726, 1053727, 1053728, 1075876, 1075877, 1075878, 1075879, 1075880, 1075881
PL	Rejestru Produktów Leczniczych	100316208, 100316214, 100316237
ZA	Health Products Regulatory Authority	48/21.2/1349, 48/21.2/1350, 48/21.2/1351